Teva Pharmaceutical Posts Lower Revenue

Analysts polled by FactSet expected Teva Pharmaceutical (TEVA) to earn 71 cents per share on $4.15 billion in sales.

During the same three months in 2023, Teva earned $1 a share and reported $4.46 billion in sales.